Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer. - PubMed - NCBI

Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer. - PubMed - NCBI

Future Oncol. 2017 Nov 23. doi: 10.2217/fon-2017-0452. [Epub ahead of print]

Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.

Havard R1, Henry NL1.

Author information

KEYWORDS:

21 gene recurrence score; 70 gene signature; breast cancer; chemotherapy; multiparameter genomic assays; prediction; prognosis

PMID:

 

29168654

 

DOI:

 

10.2217/fon-2017-0452